LON:EAHEco Animal Health Group Share Price, Forecast & News

GBX 207

0.00 (0.00 %)

(As of 06/2/2020 12:22 PM ET)

Add

Compare

Today's Range

204.50

Now: GBX 207▼

209

50-Day Range

197.50

MA: GBX 221.48▼

255

52-Week Range

110

Now: GBX 207▼

470

Volume12,095 shs

Average Volume39,512 shs

Market Capitalization£139.82 million

P/E Ratio15.56

Dividend Yield7.43%

BetaN/A

ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.

Beat the Market (BTM) Rank^™

3.5 Analyst's Opinion

Consensus Rating
Eco Animal Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 430, Eco Animal Health Group has a potential upside of 107.7% from its current price of GBX 207.
Amount of Analyst Coverage
Eco Animal Health Group has only been the subject of 1 research reports in the past 90 days.

3.0 Community Rank

Outperform Votes
Eco Animal Health Group has received 285 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Eco Animal Health Group has received 188 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Eco Animal Health Group has received 60.25% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Eco Animal Health Group and other stocks. Vote “Outperform” if you believe EAH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EAH will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Leadership
Eco Animal Health Group is a leading dividend payer. It pays a dividend yield of 7.43%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Eco Animal Health Group does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Eco Animal Health Group is 112.78 %. Payout ratios above 75% are not desirable because they may not be sustainable.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Eco Animal Health Group insiders have not sold or bought any company stock.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Eco Animal Health Group are expected to decrease by -100.00% in the coming year, from GBX 2,245.53 to GBX 0 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Eco Animal Health Group is 15.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 15.71.
Price to Earnings Ratio vs. Sector
The P/E ratio of Eco Animal Health Group is 15.56, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.40.
Price to Book Value per Share Ratio
Eco Animal Health Group has a P/B Ratio of 1.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.88 out of 5 stars

Industry, Sector and Symbol

Stock Exchange LON

Industry Drug Manufacturers - Major

Sub-IndustryN/A

SectorMedical

Current SymbolLON:EAH

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.ecoanimalhealthgroupplc.com

Phone+44-20-83362900

Debt

Debt-to-Equity Ratio2.54

Current Ratio3.58

Quick Ratio2.26

Price-To-Earnings

Trailing P/E Ratio15.56

Forward P/E Ratio0.09

P/E GrowthN/A

Sales & Book Value

Annual Sales£73.37 million

Price / Sales1.91

Cash FlowGBX 19.63 per share

Price / Cash Flow10.55

Book ValueGBX 115.30 per share

Price / Book1.80

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees207

Outstanding Shares67,547,600

Market Cap£139.82 million

Next Earnings DateN/A

OptionableNot Optionable

Receive EAH News and Ratings via Email

Sign-up to receive the latest news and ratings for EAH and its competitors with MarketBeat's FREE daily newsletter.

Eco Animal Health Group (LON:EAH) Frequently Asked Questions

How has Eco Animal Health Group's stock been impacted by COVID-19 (Coronavirus)?

Eco Animal Health Group's stock was trading at GBX 209 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, EAH shares have decreased by 1.0% and is now trading at GBX 207. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Eco Animal Health Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eco Animal Health Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Eco Animal Health Group.

How often does Eco Animal Health Group pay dividends? What is the dividend yield for Eco Animal Health Group?

Eco Animal Health Group announced a dividend on Wednesday, June 19th. Investors of record on Thursday, September 26th will be given a dividend of GBX 7.04 per share on Wednesday, October 16th. This represents a dividend yield of 1.96%. The ex-dividend date of this dividend is Thursday, September 26th. This is a positive change from Eco Animal Health Group's previous dividend of GBX 3.50. The official announcement can be viewed at this link. View Eco Animal Health Group's dividend history.

What price target have analysts set for EAH?

1 brokers have issued twelve-month price targets for Eco Animal Health Group's stock. Their forecasts range from GBX 430 to GBX 430. On average, they expect Eco Animal Health Group's stock price to reach GBX 430 in the next year. This suggests a possible upside of 107.7% from the stock's current price. View analysts' price targets for Eco Animal Health Group.

Has Eco Animal Health Group been receiving favorable news coverage?

News headlines about EAH stock have trended very positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Eco Animal Health Group earned a news impact score of 3.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutEco Animal Health Group.

Who are some of Eco Animal Health Group's key competitors?

Some companies that are related to Eco Animal Health Group include Vectura Group (VEC), Medical Developments International (MVP), BEXIMCO PHARMAC/S GDR REGS (BXP), Allergy Therapeutics (AGY), Trilogy International Partners (TRL), Recce Pharmaceuticals (RCE), Futura Medical (FUM), NanoViricides (NNVC), Vita Life Sciences (VLS), Pharmaxis (PXS), Avivagen (VIV), Antisense Therapeutics (ANP), Sareum (SAR), China Pharma (CPHI) and Patrys (PAB). View all competitors.

What other stocks do shareholders of Eco Animal Health Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eco Animal Health Group investors own include Intrepid Potash (IPI), Allena Pharmaceuticals (ALNA), Iovance Biotherapeutics (IOVA), Navios Maritime (NM), Anpario (ANP), Ampliphi Biosciences (APHB), Actinium Pharmaceuticals (ATNM), Callon Petroleum (CPE), Ekso Bionics (EKSO) and FuelCell Energy (FCEL).

Who are Eco Animal Health Group's key executives?

Eco Animal Health Group's management team includes the following people:

Mr. Marc Denham Loomes, CEO & Exec. Director (Age 58)
Mr. Kevin Anthony Stockdale BSc, ACA, Fin. Director & Exec. Director (Age 54)
Mr. Brett Clemo BA (Hons), Exec. Director (Age 57)
Ms. Julia Trouse, Sec. & Exec. Director (Age 53)

What is Eco Animal Health Group's stock symbol?

Eco Animal Health Group trades on the London Stock Exchange (LON) under the ticker symbol "EAH."

How do I buy shares of Eco Animal Health Group?

Shares of EAH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Eco Animal Health Group's stock price today?

One share of EAH stock can currently be purchased for approximately GBX 207.

How big of a company is Eco Animal Health Group?

Eco Animal Health Group has a market capitalization of £139.82 million and generates £73.37 million in revenue each year. Eco Animal Health Group employs 207 workers across the globe.

What is Eco Animal Health Group's official website?

The official website for Eco Animal Health Group is www.ecoanimalhealthgroupplc.com.

How can I contact Eco Animal Health Group?

Eco Animal Health Group's mailing address is 78 Coombe Road, NEW MALDEN, KT3 4QS, United Kingdom. The company can be reached via phone at +44-20-83362900.

This page was last updated on 6/2/2020 by MarketBeat.com Staff